Literature DB >> 1146436

[Description of a method for the determination of the number and quality of influenza virus antibody molecules by means of equilibrium centrifugation (author's transl)].

D Lubach.   

Abstract

The method of equilibrium centrifugation for determining the number of antibody molecules (A) and their equilibrium constant K characterizing the reactivity of antibody with antigen described in this paper is based on the use of virus-coated formaldehyde-treated erythrocytes as immuno-adsorbent. Graded doses of the immuno-adsorbent are mixed with the serum to be tested and the degree of antibody adsorption is measured. By analogy to the formula used in the method of equilibrium filtration, these data can be evaluated in order to determine the concentration of antibody molecules and the equilibrium constant K. Adsorption of virus on formaldehdye-treated erythrocytes results in steric hindrance of a part of the antigenic sites of the virus particles. This was taken into account by measuring sera comparatively both by means of equilibrium centrifugation and by use of equilibrium filtration and establishing correction formulas. Both techniques were found to have the same sensitivity and accuracy. In comparison to equilibrium filtration, equilibrium centrifugation offers the advantage that it can be used with test antigens which are below the minimum size needed in equilibrium filtration.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1146436

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Orig A        ISSN: 0300-9688


  2 in total

1.  Primary humoral antibody response to Coxiella burnetii, the causative agent of Q fever.

Authors:  D Guigno; B Coupland; E G Smith; I D Farrell; U Desselberger; E O Caul
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

2.  Relation of virus particle counts to the hemagglutinating activity of influenza virus suspensions measured by the HA pattern test and by use of the photometric HCU method.

Authors:  U Desselberger
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.